Damiano
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 7
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 1
-
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 1
- Co-authors
- Giampaolo Tortora (7 shared papers)Fortunato Ciardiello (7 shared papers)R. Caputo (5 shared papers)Roberto Bianco (4 shared papers)G Pomatico (3 shared papers)A R Bianco (1 shared paper)A R Bianco (5 shared papers)Sabino De Placido (5 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Haemophilia (1 paper)Acta Scientiarum Naturalium Universitatis Sunyatseni (1 paper)PubMed (1 paper)Design Automation Conference (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Damiano
10 papers receiving 886 citations
Damiano's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 562
- Pulmonary and Respiratory Medicine 377
- Radiology, Nuclear Medicine and Imaging 107
- Otorhinolaryngology 19
- Cancer Research 65
Countries citing papers authored by Damiano
This map shows the geographic impact of Damiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damiano more than expected).
Fields of papers citing papers by Damiano
This network shows the impact of papers produced by Damiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damiano. The network helps show where Damiano may publish in the future.
Co-authors
The 25 scholars most cited alongside Damiano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Hit paper breakdown → | 2000 | 860 |
| 2 | Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. | 2000 | 20 |
| 3 | 2000 | 19 | |
| 4 | L.ong-term recovery of normal sexual function in lesticular cancer survivors | 2016 | 8 |
| 5 | Antitumor activity of ZD6474, a small molecule VEGF receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to EGF receptor-targeted drugs. | 2003 | 7 |
| 6 | 2014 | 6 | |
| 7 | Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. | 2000 | 4 |
| 8 | Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity | 2003 | 3 |
| 9 | Combination of a selective cyclooxygenase-2 inhibitor with EGFR tyrosine kinase inhibitor ZD1839 (‘Iressa’) and Protein Kinase A antisense causes a cooperative antitumor and antiangiogenic effect | 2003 | 2 |
| 10 | Verification: What works and what doesn't | 2004 | 1 |
| 11 | VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. | 2008 | 0 |
About Damiano
Damiano is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Hematology and Psychiatry and Mental health, having authored 11 papers that have together received 930 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Mechanisms and Therapy (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), Gastric Cancer Management and Outcomes (1 paper), Cancer Treatment and Pharmacology (1 paper) and Cancer, Stress, Anesthesia, and Immune Response (1 paper). The work is most often cited by research in Oncology (562 citations), Pulmonary and Respiratory Medicine (377 citations), Radiology, Nuclear Medicine and Imaging (107 citations), Otorhinolaryngology (19 citations) and Cancer Research (65 citations). Damiano has collaborated with scholars based in Italy and United States. Frequent co-authors include Giampaolo Tortora, Fortunato Ciardiello, R. Caputo, Roberto Bianco, G Pomatico, A R Bianco, A R Bianco, Sabino De Placido, Ilaria Di Gregorio and Ferdinando De Vita. Their work appears in journals such as Journal of Clinical Oncology, Haemophilia, Acta Scientiarum Naturalium Universitatis Sunyatseni, PubMed and Design Automation Conference.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.